Previous Close | 20.55 |
1-Year Change | -26.26% |
6-Months Change | -38.01% |
3-Months Change | -22.72% |
Moving Avg (50d) | 21.274 |
Moving Avg (200d) | 29.128 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.546M |
Beta (3-Years) | 2.08 |
Revenue Growth (ttm) | 475.22% |
Net Profit Margin (ttm) | 33.53% |
Return On Assets (ttm) | 21.7% |
EPS (ttm) | -714.86 |
PE Ratio (ttm) | -0.03 |
Dividend Yield | 0% |
Asset Description: | Arcturus Therapeutics Holdings Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-09-10 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
20.139 | 19.522 | 19.111 | 18.495 | 17.467 | 16.44 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |